Description de l'entreprise
Indivior is a global specialty pharmaceutical company with a 20-year legacy of leadership in patient advocacy, health policy and evidence-based best practice models that have revolutionized modern addiction treatment. The name is the fusion of the words individual and endeavor, and the tagline “Focus on you” makes the company’s commitment clear. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease.
Conseil d'administration & Conseil de surveillance
| PDG |
| Mark Crossley |
| Conseil d'administration |
| Ryan Preblick, Christian Heidbreder, Cindy Cetani, Hillel West, Jon Fogle, Kathryn Hudson, Richard Simkin, Vishal Kalia, Jeffrey Burris |
| Conseil de surveillance |
| Graham Hetherington, Jerome Lande, Joanna Le Couilliard, Juliet Thompson, Mark Crossley, Mark Stejbach, Peter Bains, Ryan Preblick, Keith Humphreys, Barbara Ryan |
Données de l'entreprise
| Nom: |
Indivior PLC |
| Adresse: |
103-105 Bath Road,UK-Slough, SL1 3UH UK, Berkshire |
| Téléphone: |
+44-1753-217800 |
| Fax: |
+44-1753-217899 |
| Courriel: |
-
|
| Internet: |
indivior.com/ |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
Pharmaceuticals |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
56.31% |
| IPO date: |
- |
